Skip to main content
  • Institutional Change Required to Ditch CK-MB Testing

    Given how tough it has been to get physicians to stop ordering creatine kinase-myocardial band (CK-MB) tests for suspected acute coronary syndrome (ACS), academic physicians created guidance on the institutional elimination of this practice.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details